These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans. Guo N, Ling G, Liang X, Jin J, Fan J, Qiu J, Song Y, Huang N, Wu X, Wang X, Deng X, Deng X, Yu L. Mycoses; 2011 Sep; 54(5):e400-6. PubMed ID: 21910756 [Abstract] [Full Text] [Related]
5. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents. Shi W, Chen Z, Chen X, Cao L, Liu P, Sun S. FEMS Yeast Res; 2010 Nov; 10(7):885-93. PubMed ID: 20707818 [Abstract] [Full Text] [Related]
6. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates]. Oz Y, Akşit F, Kiraz N, Kiremitçi A. Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574 [Abstract] [Full Text] [Related]
7. Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model. Khodavandi A, Alizadeh F, Harmal NS, Sidik SM, Othman F, Sekawi Z, Jahromi MA, Ng KP, Chong PP. FEMS Microbiol Lett; 2011 Feb; 315(2):87-93. PubMed ID: 21204918 [Abstract] [Full Text] [Related]
8. Antifungal activity of thymol against clinical isolates of fluconazole-sensitive and -resistant Candida albicans. Guo N, Liu J, Wu X, Bi X, Meng R, Wang X, Xiang H, Deng X, Yu L. J Med Microbiol; 2009 Aug; 58(Pt 8):1074-1079. PubMed ID: 19528168 [Abstract] [Full Text] [Related]
12. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans. Li Y, Chang W, Zhang M, Li X, Jiao Y, Lou H. FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309 [Abstract] [Full Text] [Related]
13. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole]. Yücesoy M, Marol S. Mikrobiyol Bul; 2002 Mar; 36(3-4):317-22. PubMed ID: 12838666 [Abstract] [Full Text] [Related]
14. In vitro antifungal activity of the berberine and its synergism with fluconazole. Iwazaki RS, Endo EH, Ueda-Nakamura T, Nakamura CV, Garcia LB, Filho BP. Antonie Van Leeuwenhoek; 2010 Feb; 97(2):201-5. PubMed ID: 19882381 [Abstract] [Full Text] [Related]
15. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes. Ricardo E, Costa-de-Oliveira S, Dias AS, Guerra J, Rodrigues AG, Pina-Vaz C. FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368 [Abstract] [Full Text] [Related]
16. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans. An M, Shen H, Cao Y, Zhang J, Cai Y, Wang R, Jiang Y. Int J Antimicrob Agents; 2009 Mar; 33(3):258-63. PubMed ID: 19095412 [Abstract] [Full Text] [Related]
17. [In vitro activity of fluconazole against Candida albicans isolated from blood culture]. Pemán J, Cantón E, Orero A, Ubeda P, Viudes A, Pastor A, Gobernado M. Rev Esp Quimioter; 1998 Dec; 11(4):339-43. PubMed ID: 10336314 [Abstract] [Full Text] [Related]
19. Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans. Bulatova NR, Darwish RM. Med Princ Pract; 2008 Dec; 17(2):117-21. PubMed ID: 18287794 [Abstract] [Full Text] [Related]